These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1828835)

  • 21. Effects of KRN2391, nicorandil and diltiazem on the changes in the electrocardiogram caused by endothelin-1 in anaesthetized rats.
    Harada K; Miwa A; Kaneta S; Izawa T; Fukushima H; Ogawa N
    Br J Pharmacol; 1993 Jul; 109(3):679-84. PubMed ID: 7689399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of nicorandil in plasma using high-performance liquid chromatography with photoconductivity and ultraviolet detection. Application to pre-clinical pharmacokinetics in beagle dogs.
    Schwende FJ; Lewis RC
    J Chromatogr; 1990 Jan; 525(1):151-60. PubMed ID: 2140114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some effects of nicorandil on the smooth muscles of the rat and guinea pig.
    Weston AH
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S56-61. PubMed ID: 2447426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relaxant effects of pinacidil, nicorandil, hydralazine and nifedipine as studied in the porcine coronary artery and guinea-pig taenia coli.
    Matsui K; Ogawa Y; Imai S
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):124-33. PubMed ID: 2948465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacology of nicorandil in patients with congestive heart failure.
    Tice FD; Jungbluth GL; Binkley PF; MacKichan JJ; Mohrland JS; Wolf DL; Leier CV
    Clin Pharmacol Ther; 1992 Nov; 52(5):496-503. PubMed ID: 1424424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of skin distribution of hydrolytic activity for bioconversion of beta-estradiol 17-acetate between man and several animals in vitro.
    Hikima T; Yamada K; Kimura T; Maibach HI; Tojo K
    Eur J Pharm Biopharm; 2002 Sep; 54(2):155-60. PubMed ID: 12191686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relaxant action of nicorandil in guinea-pig isolated trachealis.
    Allen SL; Foster RW; Morgan GP; Small RC
    Br J Pharmacol; 1986 Jan; 87(1):117-27. PubMed ID: 2420397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous absorption of hexachlorophene in rats, guinea pigs and pigs.
    Chow C; Chow AY; Downie RH; Buttar HS
    Toxicology; 1978 Feb; 9(1-2):147-54. PubMed ID: 653735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment with the adenosine triphosphate-sensitive potassium channel opener nicorandil and improved myocardial protection during high-potassium cardioplegic hypoxia.
    Sugimoto S; Puddu PE; Monti F; Schiariti M; Campa PP; Marino B
    J Thorac Cardiovasc Surg; 1994 Sep; 108(3):455-66. PubMed ID: 8078338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of nicorandil in patients with normal and impaired renal function.
    Molinaro M; Villa G; Regazzi MB; Salvadeo A; Segagni S; Rondanelli R; Sartirana E
    Eur J Clin Pharmacol; 1992; 42(2):203-7. PubMed ID: 1535591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro dermal absorption of pesticides: IV. In vivo and in vitro comparison with the organophosphorus insecticide diazinon in rat, guinea pig, pig, human and tissue-cultured skin.
    Moody RP; Nadeau B
    Toxicol In Vitro; 1994 Dec; 8(6):1213-8. PubMed ID: 20693090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of percutaneous absorption and metabolism of di-n-butylphthalate in various species.
    Beydon D; Payan JP; Grandclaude MC
    Toxicol In Vitro; 2010 Feb; 24(1):71-8. PubMed ID: 19735722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation of an HPMC gel drug reservoir system with ethanol-water as a solvent system and limonene as a penetration enhancer for enhancing in vitro transdermal delivery of nicorandil.
    Al-Saidan SM; Krishnaiah YS; Chandrasekhar DV; Lalla JK; Rama B; Jayaram B; Bhaskar P
    Skin Pharmacol Physiol; 2004; 17(6):310-20. PubMed ID: 15528962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interrelationship of cardiovascular effects, plasma levels of nicorandil, and vascular cGMP formation in conscious rats.
    Sakai K; Akima M; Kamachi S; Moriyasu M; Kitajima S
    J Pharm Pharmacol; 1998 Jun; 50(6):661-6. PubMed ID: 9680078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review.
    Barbero AM; Frasch HF
    Toxicol In Vitro; 2009 Feb; 23(1):1-13. PubMed ID: 19013230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro.
    Dalton CH; Hattersley IJ; Rutter SJ; Chilcott RP
    Toxicol In Vitro; 2006 Dec; 20(8):1532-6. PubMed ID: 16904285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Model analysis of flux enhancement across hairless mouse skin induced by chemical permeation enhancers.
    He N; Warner KS; Higuchi WI; Li SK
    Int J Pharm; 2005 Jun; 297(1-2):9-21. PubMed ID: 15907593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro transdermal delivery of atenolol using mouse and guinea pig.
    Jain GK; Kaul JL; Agrawal SS
    Indian J Exp Biol; 1993 Aug; 31(8):691-3. PubMed ID: 8270284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transdermal oxymorphone formulation development and methods for evaluating flux and lag times for two skin permeation-enhancing vehicles.
    Aungst BJ; Blake JA; Rogers NJ; Hussain MA
    J Pharm Sci; 1990 Dec; 79(12):1072-6. PubMed ID: 2079653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.